Adam G. Sowalsky

Also affiliated with National Cancer Institute, Center for Cancer Research, National Institute of Mental Health

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 64 papers. Top paper: “Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response”.

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2344

N/A

1.2DataRank · unranked

38 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Defining cellular population dynamics at single-cell resolution during prostate cancer progression

eLife(2022)10.7554/elife.79076

N/A

1.1DataRank · unranked

29 citations

Sonali Arora, Ye Zheng, Erica T. Goddard, Ilsa M. Coleman, Anson T. Ku +17 more

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w

N/A

0.825DataRank · unranked

244 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics

Nature Cancer(2024)10.1038/s43018-024-00793-2

N/A

0.744DataRank · unranked

142 citations

Gal Dinstag, Eldad D. Shulman, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis +26 more

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

Nature Communications(2021)10.1038/s41467-021-27077-y

N/A

0.661DataRank · unranked

81 citations

Yiming Wu, Mannan Nouri, Sándor Spisák, Joshua W. Russo, Adam G. Sowalsky +11 more

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0559

N/A

0.590DataRank · unranked

50 citations

Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg +35 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0121

N/A

0.584DataRank · unranked

48 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-1807

N/A

0.553DataRank · unranked

39 citations

Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben +12 more

Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates

Nature Communications(2024)10.1038/s41467-024-53034-6

N/A

0.493DataRank · unranked

15 citations

Meghana S. Pagadala, Maria A. Cardenas, Roshan S. Prabhu, Subir Goyal, Chengjing Zhou +34 more

Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer

Cell Reports(2024)10.1016/j.celrep.2024.115089

N/A

0.455DataRank · unranked

12 citations

Mannan Nouri, Jiaqian Liang, Shaoyong Chen, Andreas Varkaris, Betul Ersoy-Fazlioglu +15 more

ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics

Modern Pathology(2025)10.1016/j.modpat.2025.100777

N/A

0.396DataRank · unranked

13 citations

Rong Rong Huang, Brian Cone, Sung‐Hae Kang, Reza Setoodeh, Anthony Sisk +5 more

GZMK+CD8+ T cells target a specific acinar cell type in Sjögren's disease

Annals of the Rheumatic Diseases(2025)10.1016/j.ard.2025.08.014

N/A

0.385DataRank · unranked

12 citations

Paola Pérez, Anson T. Ku, Bruno Fernandes Matuck, Khoa Huynh, Shunsuke Sakai +38 more

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

Discover Oncology(2022)10.1007/s12672-022-00565-3

N/A

0.330DataRank · unranked

8 citations

Margaret White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang +10 more

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

Research Square(2023)10.21203/rs.3.rs-3193270/v1

N/A

0.292DataRank · unranked

6 citations

Danh-Tai Hoang, Gal Dinstag, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis +25 more

Prediction of cancer treatment response from histopathology images through imputed transcriptomics.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1551

N/A

0.292DataRank · unranked

6 citations

Gal Dinstag, Leandro C. Hermida, Doreen S. Ben-Zvi, Chani Stossel, Tejas Patil +15 more

Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis

The Prostate(2024)10.1002/pros.24718

N/A

0.241DataRank · unranked

4 citations

Asha Daryanani, Lu Fan, Anson T. Ku, John R. Bright, Aian Neil Alilin +13 more

Localized high-risk prostate cancer harbors an androgen receptor activity–low subpopulation susceptible to HER2 inhibition

Journal of Clinical Investigation(2025)10.1172/jci189900

N/A

0.172DataRank · unranked

2 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +26 more

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways

Cell Reports(2025)10.1016/j.celrep.2025.115779

N/A

0.165DataRank · unranked

2 citations

Subhiksha Nandakumar, Nabila Zaman, Prathiksha Prabhakaraalva, Sarah Ann King, Teja Kalidindi +19 more

Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2186

N/A

0.165DataRank · unranked

2 citations

Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Sumeyra Kartal, Houssein Abdul Sater +25 more

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

medRxiv(2022)10.1101/2022.03.10.22271799

N/A

0.165DataRank · unranked

2 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi’s Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate

European Urology(2021)10.1016/j.eururo.2021.06.002

N/A

0.104DataRank · unranked

1 citations

Huihui Ye, Rosina T. Lis, Adam G. Sowalsky, Scott Wilkinson

Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.10.575110

N/A

0.104DataRank · unranked

1 citations

Mannan Nouri, Jiaqian Liang, Andreas Varkaris, Betul Ersoy-Fazlioglu, Olga Voznesensky +14 more

FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0248

N/A

0DataRank · unranked

10 citations

Lia DePaula Oliveira, Ethan Schaffer, Thiago Vidotto, Adrianna A. Mendes, Jiayun Lu +11 more

One toolkit to bring them all, and in silico analyze them

Clinical and Translational Discovery(2023)10.1002/ctd2.194

N/A

0DataRank · unranked

2 citations

Anna Baj, Adam G. Sowalsky, Chennan Li

Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad192

N/A

0DataRank · unranked

1 citations

Adam G. Sowalsky, Scott Wilkinson

GZMK+CD8+ T cells Target a Specific Acinar Cell Type in Sjögren’s Disease

Research Square(2023)10.21203/rs.3.rs-3601404/v1

N/A

0DataRank · unranked

19 citations

Thomas Pranzatelli, Paola Pérez, Anson T. Ku, Bruno Fernandes Matuck, Khoa Huynh +37 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387.v1

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/0008-5472.c.6513813.v1

N/A

0DataRank · unranked

0 citations

Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben +12 more

A case report of multiple primary prostate tumors with differential drug sensitivity

Nature Communications(2020)10.1038/s41467-020-14657-7

N/A

0DataRank · unranked

40 citations

Stephanie A. Harmon, Nicholas T. Terrigino, Fatima Karzai, Peter A. Pinto, Ravi A. Madan +16 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054.v1

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

(2023)10.1158/1078-0432.c.6532445

N/A

0DataRank · unranked

0 citations

Ines Figueiredo, Rosina T. Lis, Ilsa M. Coleman, Bora Gurel, Denisa Bogdan +26 more

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence

The Medicine Forum(2023)10.1101/2023.05.01.23288883

N/A

0DataRank · unranked

0 citations

Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Houssein Abdul Sater, Stephanie A. Harmon +12 more

Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer

Stem Cells(2024)10.1093/stmcls/sxae025

N/A

0DataRank · unranked

6 citations

Brian J. Capaldo, Ross Lake, Anson T. Ku, Danielle Burner, Caitlin M. Tice +12 more

GZMK+CD8+ T cells Target A Specific Acinar Cell Type in Sjögren’s Disease

Research Square(2024)10.21203/rs.3.rs-3601404/v2

N/A

0DataRank · unranked

5 citations

Paola Pérez, Anson T. Ku, Bruno Fernandes Matuck, Khoa Huynh, Shunsuke Sakai +38 more

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

medRxiv(2024)10.1101/2024.02.09.24302395

N/A

0DataRank · unranked

4 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +21 more

77P Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

ESMO Open(2024)10.1016/j.esmoop.2024.103818

N/A

0DataRank · unranked

0 citations

D. Westaby, Ines Figueiredo, A. De Haven Brandon, Ana Padilha, W. Yuan +15 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7–Expressing CRPC Models

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0096

N/A

0DataRank · unranked

4 citations

Andres F. Leon, Erica L. Beatson, Jessica D. Kindrick, Kinjal Bhadresha, Xiaohu Zhang +15 more

Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion

Journal of Clinical Investigation(2025)10.1172/jci192368

N/A

0DataRank · unranked

1 citations

Sen Chen, Luigi Cecchi, Betul Ersoy-Fazlioglu, Joshua W. Russo, Seiji Arai +16 more

TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.17.633582

N/A

0DataRank · unranked

1 citations

Rishita Chatterjee, Boobash Raj Selvadurai, Lipika R. Pal, Aakanksha Verma, Nishanth Belugali Nataraj +31 more

Discovery and performance of DNA methylation panels for cancer detection and classification in blood

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.16.676542

N/A

0DataRank · unranked

0 citations

Sara R. Bang-Christensen, Sara A. Grimm, Brian D. Bennett, Peter Kilfeather, Kevin Fedkenheuer +12 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity

Oncogene(2020)10.1038/s41388-020-01389-7

N/A

0DataRank · unranked

34 citations

Shana Y. Trostel, Scott Wilkinson, Nicholas T. Terrigino, S. Thomas Hennigan, Ross Lake +8 more

AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification

Cancer Treatment and Research Communications(2020)10.1016/j.ctarc.2020.100218

N/A

0DataRank · unranked

3 citations

Adam Sharp, Shana Y. Trostel, Johann S. De Bono, Stephen R. Plymate, Adam G. Sowalsky

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

medRxiv(2020)10.1101/2020.09.29.20199711

N/A

0DataRank · unranked

12 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.368

N/A

0DataRank · unranked

0 citations

Ravi A. Madan, Adam G. Sowalsky, Marijo Bilušić, Guinevere Chun, Lisa M. Cordes +9 more

Multiple primary prostate tumors with differential drug sensitivity.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.342

N/A

0DataRank · unranked

0 citations

Huihui Ye, Nicholas T. Terrigino, Nicole V. Carrabba, Rayann Atway, Shana Y. Trostel +14 more

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

European Urology(2021)10.1016/j.eururo.2020.12.037

N/A

0DataRank · unranked

94 citations

Alejandro Athie, Paul C. Boutros, Marzia Del Re, David T. Miyamoto, Kenneth J. Pienta +6 more

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

European Urology(2021)10.1016/j.eururo.2021.03.009

N/A

0DataRank · unranked

74 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors

JCO Precision Oncology(2021)10.1200/po.21.00059

N/A

0DataRank · unranked

17 citations

Seiji Arai, Carla Calagua, Fang Xie, Olga Voznesensky, Brian J. Capaldo +6 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

medRxiv(2021)10.1101/2021.01.27.21250464

N/A

0DataRank · unranked

4 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Comparison of Approaches to Transcriptomic Analysis in Multi-Sampled Tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.11.443668

N/A

0DataRank · unranked

2 citations

Scott Wilkinson, Adam G. Sowalsky, Anson T. Ku

Prostate-specific membrane antigen is a biomarker for residual disease following neoadjuvant intense androgen deprivation therapy in prostate cancer

medRxiv(2021)10.1101/2021.10.28.21265614

N/A

0DataRank · unranked

0 citations

Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Shana Y. Trostel, Nicole V. Carrabba +5 more

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0851

N/A

0DataRank · unranked

32 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Modeling Androgen Deprivation Therapy–Induced Prostate Cancer Dormancy and Its Clinical Implications

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-1037

N/A

0DataRank · unranked

25 citations

Hui Xue, Fan Mo, Yen-yi Lin, Dong Lin, Nelson K.Y. Wong +16 more

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

The Journal of Urology(2022)10.1097/ju.0000000000002492

N/A

0DataRank · unranked

5 citations

Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Nichelle C. Whitlock, Shana Y. Trostel +6 more

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.07.495219

N/A

0DataRank · unranked

9 citations

Gal Dinstag, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis, Katherine Caley +25 more

The origin and dynamics of cellular heterogeneity vary across lineage subtypes of castrate resistant prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.24.484651

N/A

0DataRank · unranked

3 citations

Brian J. Capaldo, Ross Lake, Anson T. Ku, Danielle Burner, Caitlin M. Tice +12 more

Defining cellular population dynamics at single cell resolution during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.02.482711

N/A

0DataRank · unranked

2 citations

Sonali Arora, Ye Zheng, Erica T. Goddard, Ilsa M. Coleman, Anson T. Ku +13 more

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

medRxiv(2022)10.1101/2022.06.04.22276001

N/A

0DataRank · unranked

1 citations

Margaret White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang +10 more

Comment on: Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis by Jing Li et al.

Translational Oncology(2022)10.1016/j.tranon.2022.101347

N/A

0DataRank · unranked

0 citations

Adam G. Sowalsky, Scott Wilkinson

1033 Stem-like CD8 T-cells residing in antigen presenting immune niches are prognostic for local control in brain metastases and are sustained following radiation therapy

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1033

N/A

0DataRank · unranked

0 citations

Prasanthi Chappa, Nataliya Prokhnevska, Maria F. Cardenas, Roshan S. Prabhu, Jim Zhong +20 more

Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models

Journal of Clinical Investigation(2023)10.1172/jci162148

N/A

0DataRank · unranked

32 citations

Lei Fang, Kerry M. McGowen, JuanJuan Yin, Joel Bowman, Anson T. Ku +17 more